Diagnosing breast cancer using Raman spectroscopy: prospective analysis

Abigail S. Haka, Zoya Volynskaya, Joseph A. Gardecki, and Jon Nazemi Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 Robert Shenk and Nancy Wang University Hospitals Case Medical Center and Case Wester...

Full description

Bibliographic Details
Main Authors: Haka, Abigail S., Gardecki, Joseph A., Nazemi, Jonathan H., Volynskaya, Zoya I., Shenk, Robert, Wang, Nancy, Dasari, Ramachandra Rao, Fitzmaurice, Maryann, Feld, Michael S.
Other Authors: Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Format: Article
Language:en_US
Published: Society of Photo-Optical Instrumentation Engineers 2010
Online Access:http://hdl.handle.net/1721.1/51360
_version_ 1826200233817669632
author Haka, Abigail S.
Gardecki, Joseph A.
Nazemi, Jonathan H.
Volynskaya, Zoya I.
Shenk, Robert
Wang, Nancy
Dasari, Ramachandra Rao
Fitzmaurice, Maryann
Feld, Michael S.
author2 Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
author_facet Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science
Haka, Abigail S.
Gardecki, Joseph A.
Nazemi, Jonathan H.
Volynskaya, Zoya I.
Shenk, Robert
Wang, Nancy
Dasari, Ramachandra Rao
Fitzmaurice, Maryann
Feld, Michael S.
author_sort Haka, Abigail S.
collection MIT
description Abigail S. Haka, Zoya Volynskaya, Joseph A. Gardecki, and Jon Nazemi Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 Robert Shenk and Nancy Wang University Hospitals Case Medical Center and Case Western Reserve, 11100 Euclid Avenue, Cleveland Ohio 44106 Ramachandra R. Dasari Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 Maryann Fitzmaurice University Hospitals Case Medical Center and Case Western Reserve, 11100 Euclid Avenue, Cleveland Ohio 44106 Michael S. Feld Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 We present the first prospective test of Raman spectroscopy in diagnosing normal, benign, and malignant human breast tissues. Prospective testing of spectral diagnostic algorithms allows clinicians to accurately assess the diagnostic information contained in, and any bias of, the spectroscopic measurement. In previous work, we developed an accurate, internally validated algorithm for breast cancer diagnosis based on analysis of Raman spectra acquired from fresh-frozen in vitro tissue samples. We currently evaluate the performance of this algorithm prospectively on a large ex vivo clinical data set that closely mimics the in vivo environment. Spectroscopic data were collected from freshly excised surgical specimens, and 129 tissue sites from 21 patients were examined. Prospective application of the algorithm to the clinical data set resulted in a sensitivity of 83%, a specificity of 93%, a positive predictive value of 36%, and a negative predictive value of 99% for distinguishing cancerous from normal and benign tissues. The performance of the algorithm in different patient populations is discussed. Sources of bias in the in vitro calibration and ex vivo prospective data sets, including disease prevalence and disease spectrum, are examined and analytical methods for comparison provided.
first_indexed 2024-09-23T11:33:39Z
format Article
id mit-1721.1/51360
institution Massachusetts Institute of Technology
language en_US
last_indexed 2024-09-23T11:33:39Z
publishDate 2010
publisher Society of Photo-Optical Instrumentation Engineers
record_format dspace
spelling mit-1721.1/513602022-10-01T04:24:44Z Diagnosing breast cancer using Raman spectroscopy: prospective analysis Haka, Abigail S. Gardecki, Joseph A. Nazemi, Jonathan H. Volynskaya, Zoya I. Shenk, Robert Wang, Nancy Dasari, Ramachandra Rao Fitzmaurice, Maryann Feld, Michael S. Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science Massachusetts Institute of Technology. Department of Physics Massachusetts Institute of Technology. Spectroscopy Laboratory Feld, Michael S. Haka, Abigail S. Gardecki, Joseph A. Nazemi, Jonathan H. Volynskaya, Zoya I. Dasari, Ramachandra Rao Feld, Michael S. Abigail S. Haka, Zoya Volynskaya, Joseph A. Gardecki, and Jon Nazemi Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 Robert Shenk and Nancy Wang University Hospitals Case Medical Center and Case Western Reserve, 11100 Euclid Avenue, Cleveland Ohio 44106 Ramachandra R. Dasari Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 Maryann Fitzmaurice University Hospitals Case Medical Center and Case Western Reserve, 11100 Euclid Avenue, Cleveland Ohio 44106 Michael S. Feld Massachusetts Institute of Technology, George R. Harrison Spectroscopy Laboratory, 77 Massachusetts Avenue, Cambridge, Massachusetts 02139 We present the first prospective test of Raman spectroscopy in diagnosing normal, benign, and malignant human breast tissues. Prospective testing of spectral diagnostic algorithms allows clinicians to accurately assess the diagnostic information contained in, and any bias of, the spectroscopic measurement. In previous work, we developed an accurate, internally validated algorithm for breast cancer diagnosis based on analysis of Raman spectra acquired from fresh-frozen in vitro tissue samples. We currently evaluate the performance of this algorithm prospectively on a large ex vivo clinical data set that closely mimics the in vivo environment. Spectroscopic data were collected from freshly excised surgical specimens, and 129 tissue sites from 21 patients were examined. Prospective application of the algorithm to the clinical data set resulted in a sensitivity of 83%, a specificity of 93%, a positive predictive value of 36%, and a negative predictive value of 99% for distinguishing cancerous from normal and benign tissues. The performance of the algorithm in different patient populations is discussed. Sources of bias in the in vitro calibration and ex vivo prospective data sets, including disease prevalence and disease spectrum, are examined and analytical methods for comparison provided. Pathology Associates of University Hospitals National Center for Research Resources National Institutes of Health 2010-02-05T13:30:17Z 2010-02-05T13:30:17Z 2009-10 2009-07 Article http://purl.org/eprint/type/JournalArticle 1083-3668 http://hdl.handle.net/1721.1/51360 Haka, Abigail S. et al. “Diagnosing breast cancer using Raman spectroscopy: prospective analysis.” Journal of Biomedical Optics 14.5 (2009): 054023-8. en_US http://dx.doi.org/10.1117/1.3247154 Journal of Biomedical Optics Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. application/pdf Society of Photo-Optical Instrumentation Engineers Michael Feld webpage
spellingShingle Haka, Abigail S.
Gardecki, Joseph A.
Nazemi, Jonathan H.
Volynskaya, Zoya I.
Shenk, Robert
Wang, Nancy
Dasari, Ramachandra Rao
Fitzmaurice, Maryann
Feld, Michael S.
Diagnosing breast cancer using Raman spectroscopy: prospective analysis
title Diagnosing breast cancer using Raman spectroscopy: prospective analysis
title_full Diagnosing breast cancer using Raman spectroscopy: prospective analysis
title_fullStr Diagnosing breast cancer using Raman spectroscopy: prospective analysis
title_full_unstemmed Diagnosing breast cancer using Raman spectroscopy: prospective analysis
title_short Diagnosing breast cancer using Raman spectroscopy: prospective analysis
title_sort diagnosing breast cancer using raman spectroscopy prospective analysis
url http://hdl.handle.net/1721.1/51360
work_keys_str_mv AT hakaabigails diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT gardeckijosepha diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT nazemijonathanh diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT volynskayazoyai diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT shenkrobert diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT wangnancy diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT dasariramachandrarao diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT fitzmauricemaryann diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis
AT feldmichaels diagnosingbreastcancerusingramanspectroscopyprospectiveanalysis